MedTrace Logo

The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination

NCT03194555 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-04-10

Study results available
· View outcomes & findings →

Summary

The Preventive Treatment of Migraine with Low-Dose Naltrexone and Acetaminophen Combination: A Small, Randomized, Double-Blind, and Placebo-Controlled Clinical Trial with an Open-Label Extension for None-Responders

Conditions

  • Migraine With or Without Aura

Interventions

DRUG

Low-Dose Naltrexone and Acetaminophen Combination

Twice daily

DRUG

Placebo

Twice daily

Sponsors & Collaborators

  • Allodynic Therapeutics, Inc

    lead INDUSTRY

Principal Investigators

  • Annette Toledano, M.D. · Allodynic Therapeutics, Inc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-25
Primary Completion
2018-07-26
Completion
2018-07-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03194555 on ClinicalTrials.gov